Matthew Gline, CEO: Roivant Sciences ROIV Sell · Filed 04/20

Trade details

Type: Insider sale
Amount: $8,449,809.84
Shares · price: 289,774 sh · $29.16 a share
Held after: 16,736,116 sh
Stock: Roivant Sciences ROIV
Person: Matthew GlineCEO
Trade date: 26/04/16
Filed: 26/04/20
Days to filing: 4 days

Sold 1.7% of holdings

Share of holding sold: 1.7%

Roivant Sciences trades, last 26 weeks

What else happened in Roivant Sciences around then

Filed or reported within 30 days of the trade day · 03/17~05/16

Matthew Gline's recent trades

Matthew GlineCEO
Planned saleRoivant Sciences
Planned sale
Roivant Sciences
ROIV
$8.4M
289,774 sh
$8.4M
Filed 04/16
Traded 04/16
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$20.5M
943,527 sh
$20.5M
Filed 25/12/17
Traded 25/12/15
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$12.3M
566,116 sh
$12.3M
Filed 25/12/17
Traded 25/12/15
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$5M
230,357 sh
$5M
Filed 25/12/17
Traded 25/12/15
Matthew GlineCEO
Planned saleRoivant Sciences
Planned sale
Roivant Sciences
ROIV
$37.7M
1,740,000 sh
$37.7M
Filed 25/12/15
Traded 25/12/15